Chemed Corporation (CHE) Tops Q3 EPS by 54c

Chemed Corporation (NYSE: CHE) reported Q3 EPS of $5.06, $0.54 better than the analyst estimate of $4.52. Revenue for the quarter came in at $539 million versus the consensus estimate of $531.87 million.

GUIDANCE:

Chemed Corporation sees FY2021 EPS of $17.00-$17.50, versus the consensus of $17.91.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
• zSpace, Inc. (ZSPC) Reports Q2 results